Article

Impact of transcervical resection of endometrium on uterine and ovarian haemodynamics.

Hysteroscopic Centre, Fuxing Hospital, Capital Medical University, Beijing 100038, China.
Reproductive biomedicine online (Impact Factor: 2.98). 08/2007; 15(1):57-62. DOI: 10.1016/S1472-6483(10)60692-X
Source: PubMed

ABSTRACT This study prospectively evaluated the impact of transcervical resection of endometrium (TCRE) on uterine and ovarian haemodynamics. The study group comprised 35 women with abnormal (excessive) uterine bleeding who underwent TCRE. The patients were examined by transvaginal colour Doppler ultrasonography 1-4 days prior to operation, and then 1, 3, 6 and 12 months post-operatively, to measure resistance index (RI) and pulsatility index from uterine, arcuate, radial and ovarian arteries. Thirty-five patients were followed up for 1 year after TCRE. Thirty (85.7%) patients had adequately controlled menorrhagia as defined by the patients subjectively. Nine (25.7%) patients had amenorrhoea, 21 (60%) patients had hypomenorrhoea and five (14.3%) patients had lighter periods initially but the menorrhagia recurred within 1 year after the operation. However, patients who had relapse of menorrhagia at 1 year after TCRE had a lower RI at all levels of uterine arteries compared with those who had persistent improvement. The data suggest that patients who had TCRE per se did not have associated altered uterine and ovarian haemodynamics; however, compared with those who had persistent improvement, those who had relapse in symptoms had an associated lower RI (P < or = 0.01) after TCRE at all levels of uterine arteries.

0 Followers
 · 
70 Views
 · 
0 Downloads
  • Source
    • "No complication was observed and in 73.5% of the cases diagnostic and therapeutic measures had led to the treatment of uterine bleeding. Liu et al (2007) in a study on 35 females with abnormal uterine bleeding found that treatments using hysteroscopy were successful in 85.7% of the cases (8). In the study of Engelsen et al (2006) which was carried out on 386 females with abnormal uterine bleeding, hysteroscopy was successful in 83.4% of the cases (9). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Hysteroscopy is a safe and high efficient procedure so it is changing to a widespread procedure in dealing with many gynecologic and obstetrical conditions. Objective: This study aimed to evaluate the diagnostic and therapeutical efficiency of hysteroscopy in managing the common conditions including abnormal uterine bleeding, abortion and infertility. Materials and Methods: This was a descriptive cross-sectional study to compare hysteroscopy as a minimally invasive approach with conventional laparatomy and hysterectomy or repair of mulerian anomalies and watch the uterine cavity for intrauterine pathology in cases of infertility. Overall 277 women underwent hysteroscopy were evaluated in three groups: with AUB 226 cases, with infertility 34 cases and with recurrent abortions with septate uterus17 cases. The overall success rate was recorded and analyzed after six months in order of indication of hysteroscopy Results: Hysteroscopy as sole diagnostic procedure in 16.5, 8.8 and 14.3%of AUB, infertility and abortion cases, respectively. In AUB cases, curettage, myomectomy, polypectomy and hysterectomy were the main diagnostic-therapeutical approaches along with hysteroscopy. In infertiles, myomectomy, polypectomy were the main diagnostic-therapeutical approaches In abortion group, laparoscopy guided, septum resection adhessiolysis , curettage and myomectomy were the main aproach. There was not any major complication. The diagnostic-therapeutically measures accompanying with the hysteroscopy were successful in 73.5% of the bleeding group and 33.3% of the infertility group in follow-up period. Conclusion: Based on our results, hysteroscopy is a safe, accurate and highly-efficient procedure in managing women with abnormal uterine bleeding, recurrent abortion due to septate uterus
    Iranian Journal of Reproductive Medicine 07/2012; 10(4):377-82. · 0.19 Impact Factor